.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Citi
Queensland Health
Deloitte
Harvard Business School
Fuji
Fish and Richardson
Mallinckrodt
Cerilliant

Generated: July 21, 2017

DrugPatentWatch Database Preview

Fluocinonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluocinonide and what is the scope of fluocinonide patent protection?

Fluocinonide
is the generic ingredient in five branded drugs marketed by Taro, G And W Labs Inc, Fougera Pharms, Cnty Line Pharms, Teva, Teva Pharms, Fougera Pharms Inc, Fougera, Perrigo Israel, Medicis, Glenmark Generics, and Perrigo New York, and is included in thirty-one NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Fluocinonide has eleven patent family members in nine countries.

There are nine drug master file entries for fluocinonide. Thirty suppliers are listed for this compound.

Summary for Generic Name: fluocinonide

Tradenames:5
Patents:5
Applicants:12
NDAs:31
Drug Master File Entries: see list9
Suppliers / Packagers: see list30
Bulk Api Vendors: see list43
Clinical Trials: see list8
Patent Applications: see list5,671
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluocinonide at DailyMed

Pharmacology for Ingredient: fluocinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
FLUOCINONIDE EMULSIFIED BASE
fluocinonide
CREAM;TOPICAL072494-001Jan 19, 1989AB2RXNoYes► Subscribe► Subscribe
G And W Labs Inc
FLUOCINONIDE EMULSIFIED BASE
fluocinonide
CREAM;TOPICAL074204-001Jun 13, 1995AB2RXNoNo► Subscribe► Subscribe
G And W Labs Inc
FLUOCINONIDE
fluocinonide
GEL;TOPICAL072537-001Feb 7, 1989ABRXNoNo► Subscribe► Subscribe
Taro
FLUOCINONIDE
fluocinonide
SOLUTION;TOPICAL074799-001Dec 31, 1996ATRXNoYes► Subscribe► Subscribe
Fougera Pharms Inc
FLUOCINONIDE
fluocinonide
GEL;TOPICAL072933-001Dec 30, 1994ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fluocinonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms
LIDEX
fluocinonide
CREAM;TOPICAL016908-002Approved Prior to Jan 1, 19823,592,930► Subscribe
Cnty Line Pharms
LIDEX
fluocinonide
OINTMENT;TOPICAL016909-002Approved Prior to Jan 1, 19824,017,615► Subscribe
Cnty Line Pharms
LIDEX
fluocinonide
CREAM;TOPICAL016908-002Approved Prior to Jan 1, 19823,888,995► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: fluocinonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,217,422Compositions and methods for enhancing corticosteroid delivery► Subscribe
7,771,733Compositions and methods for enhancing corticosteroid delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fluocinonide

Country Document Number Estimated Expiration
Japan2010280689► Subscribe
MexicoPA04006014► Subscribe
China1617730► Subscribe
Australia2002360589► Subscribe
European Patent Office2363150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Teva
Merck
McKinsey
Argus Health
Queensland Health
Boehringer Ingelheim
Medtronic
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot